Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.

Peter V DicpinigaitisAlyn H MoriceJaclyn A SmithMandel R SherMichael VaeziLaurent GuilleminaultAkio NiimiKerstin GudeUlrike KrahnRiitta SaarinenPhilippe Vieira PiresMelanie WosnitzaLorcan P McGarveynull null

Published in: Lung (2023)

ClinicalTrials.gov identifier NCT04562155; registered September 18, 2020.

Keyphrases

placebo controlled
double blind
phase ii
phase iii
open label
clinical trial
phase ii study
randomized controlled trial